Pancreatic Cancer Research

ResearcherSalk Institute for Biological StudiesActive in the last 2 years

Satoshi Ogawa

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4970-4212; OpenAlex author ID A5101546127. Sources: OpenAlex.

Their work

Papers
10
Trials
0
Grants
0
Labs led
0
Collaborators
36
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 4 papers

Papers 10

  1. Corrigendum to Polybromo 1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer. Co-author DOI 10.1172/jci206371↗
  2. CA19-9 promotes liver metastasis of pancreatic cancer through E-selectin mediated extravasation Co-author DOI 10.64898/2026.04.08.717301↗
  3. Metabolic Salvage and Acyl-chain Remodeling Support Glycosphingolipid Synthesis within the PDAC Tumor Microenvironment Co-author DOI 10.64898/2026.04.14.718544↗
  4. CA19-9 induces microenvironment remodeling in pancreatic ductal adenocarcinoma Co-author DOI 10.64898/2026.05.22.727290↗
  5. Reduction of butyrate-producing bacteria in the gut microbiome of Japanese patients with pancreatic cancer. Co-author DOI 10.1016/j.pan.2024.09.002↗
  6. Dual Inhibition of KRASG12D and Pan-ERBB Is Synergistic in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-23-1313↗
  7. Visualization of stem cell activity in pancreatic cancer expansion by direct lineage tracing with live imaging. Co-author DOI 10.7554/elife.55117↗
  8. Nardilysin inhibits pancreatitis and suppresses pancreatic ductal adenocarcinoma initiation in mice. Co-author DOI 10.1136/gutjnl-2017-315425↗
  9. ARID1A Maintains Differentiation of Pancreatic Ductal Cells and Inhibits Development of Pancreatic Ductal Adenocarcinoma in Mice. Co-author DOI 10.1053/j.gastro.2018.03.039↗
  10. [A case of jejunal ectopic pancreatic cancer: the diagnostic usefulness of MRI]. Co-author DOI 10.11405/nisshoshi.112.70↗

Closest collaborators

The 25 strongest of 36 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Andrew M. Lowy · 4 shared papers, 2023–2026 · strength 0.84
  2. Dannielle D. Engle · 4 shared papers, 2023–2026 · strength 0.84
  3. Hervé Tiriac · 4 shared papers, 2023–2026 · strength 0.84
  4. Casie S. Kubota · 3 shared papers, 2026 · strength 0.68
  5. Takahisa Maruno · 5 shared papers, 2018–2026 · strength 0.63
  6. Hiroshi Seno · 5 shared papers, 2018–2026 · strength 0.63
  7. Akihisa Fukuda · 5 shared papers, 2018–2026 · strength 0.63
  8. Motoyuki Tsuda · 4 shared papers, 2018–2026 · strength 0.46
  9. Jasper Hsu · 2 shared papers, 2026 · strength 0.42
  10. Hyemin Song · 2 shared papers, 2026 · strength 0.42
  11. Ronald M. Evans · 2 shared papers, 2026 · strength 0.42
  12. Jonathan Weitz · 2 shared papers, 2023–2026 · strength 0.41
  13. Toshihiko Masui · 2 shared papers, 2024–2026 · strength 0.38
  14. Makoto Sono · 2 shared papers, 2024–2026 · strength 0.38
  15. Etsuro Hatano · 2 shared papers, 2024–2026 · strength 0.38
  16. Kei Iimori · 2 shared papers, 2024–2026 · strength 0.38
  17. Dieter Saur · 2 shared papers, 2021–2026 · strength 0.32
  18. Osamu Araki · 2 shared papers, 2018–2026 · strength 0.28
  19. Christian M. Metallo · 1 shared paper, 2026 · strength 0.26
  20. Anna Trimble · 1 shared paper, 2026 · strength 0.26
  21. Kozo Ikuta · 3 shared papers, 2018–2021 · strength 0.25
  22. Tsutomu Chiba · 3 shared papers, 2018–2021 · strength 0.25
  23. Shinji Üemoto · 3 shared papers, 2018–2021 · strength 0.25
  24. Kyoichi Takaori · 3 shared papers, 2018–2021 · strength 0.25
  25. Munenori Kawai · 1 shared paper, 2026 · strength 0.21

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.